Argentina, Australia, Brazil, Canada, Chile, Colombia, Germany, Hungary, India, Korea (South), Latvia, Lithuania, Mexico, New Zealand, Poland, Romania, Russian Federation, Sweden, Taiwan, Republic of China, United Kingdom, United States of America
This is an international multi-country randomized controlled trial conducted in 9901 people with type 2 diabetes in 20 countries. It is assessing the effect of a approximately 5 years therapy with a once weekly injectable drug on serious health outcomes in people with type 2 diabetes.
Impact
May change the way that diabetes is managed worldwide
Student Experience
Provides training for students interested in international clinical trials
Countries
Argentina, Australia, Brazil, Canada, Chile, Colombia, Germany, Hungary, India, Korea (South), Latvia, Lithuania, Mexico, New Zealand, Poland, Romania, Russian Federation, Sweden, Taiwan, Republic of China, United Kingdom, United States of America
